Bellevue Group AG
- SEC CIK
- 0001674546
- Latest filing
- Aug 14, 2026
Holdings in Q2 2025
Holdings as of Jun 30, 2025, filed Aug 14, 2025. Long positions only; changes compare share counts with Q1 2025.
- Positions
- 142
- −6 vs. Q1 2025
- Portfolio value
- $4.54B
- +$74.3M (+1.7%) vs. Q1 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PRCTPROCEPT BioRobotics Corp | COM | 489,278 | $28.2M | 0.6% | +74,355+17.9% | Added | History |
| RLAYRelay Therapeutics, Inc. | COM | 8,230,870 | $28.5M | 0.6% | +853,578+11.6% | Added | History |
| ALGNAlign Technology Inc | COM | 150,787 | $28.5M | 0.6% | −206−0.1% | Reduced | History |
| ABBVAbbVie Inc. | Stock | 159,661 | $29.6M | 0.7% | +24,421+18.1% | Added | History |
| MCKMcKesson Corp | Stock | 40,466 | $29.7M | 0.7% | +9,886+32.3% | Added | History |
| LLYEli Lilly & Co | Stock | 40,920 | $31.9M | 0.7% | −2,727−6.2% | Reduced | History |
| ELVElevance Health, Inc. | Stock | 82,053 | $31.9M | 0.7% | +41,995+104.8% | Added | History |
| VEEVVeeva Systems Inc | Stock | 113,333 | $32.6M | 0.7% | +83+0.1% | Added | History |
| MRNAModerna, Inc. | Stock | 1,238,668 | $34.2M | 0.8% | −279,454−18.4% | Reduced | History |
| EWTXEdgewise Therapeutics, Inc. | COM | 2,775,997 | $36.4M | 0.8% | +1,347,068+94.3% | Added | History |
| BPMCBlueprint Medicines Corp | COM | 284,900 | $36.5M | 0.8% | +284,900 | New | History |
| CICigna Group | Stock | 110,712 | $36.6M | 0.8% | −6,823−5.8% | Reduced | History |
| HCAHCA Healthcare, Inc. | COM | 99,122 | $38.0M | 0.8% | +37,315+60.4% | Added | History |
| GEHCGE HealthCare Technologies Inc. | Stock | 515,468 | $38.2M | 0.8% | −8,946−1.7% | Reduced | History |
| BHVNBiohaven Ltd. | COM | 2,802,853 | $39.5M | 0.9% | +762,000+37.3% | Added | History |
| IDXXIDEXX Laboratories Inc | COM | 76,548 | $41.1M | 0.9% | −349−0.5% | Reduced | History |
| RMDResmed Inc | COM | 165,802 | $42.8M | 0.9% | 00.0% | Unchanged | History |
| UNHUnitedHealth Group Inc | Stock | 142,296 | $44.4M | 1.0% | −22,446−13.6% | Reduced | History |
| PENPenumbra Inc | COM | 174,050 | $44.7M | 1.0% | −30,467−14.9% | Reduced | History |
| TMOThermo Fisher Scientific Inc. | Stock | 113,544 | $46.0M | 1.0% | +49,312+76.8% | Added | History |
| BEAMBeam Therapeutics Inc. | COM | 2,889,288 | $49.1M | 1.1% | +493,358+20.6% | Added | History |
| BDXBecton Dickinson & Co | Stock | 316,732 | $54.6M | 1.2% | −27,579−8.0% | Reduced | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 3,307,569 | $67.3M | 1.5% | +235,954+7.7% | Added | History |
| PODDInsulet Corp | Stock | 219,013 | $68.8M | 1.5% | −52,273−19.3% | Reduced | History |
| EWEdwards Lifesciences Corp | Stock | 889,077 | $69.5M | 1.5% | −82,892−8.5% | Reduced | History |
| DXCMDexcom Inc | COM | 860,828 | $75.1M | 1.7% | −203,280−19.1% | Reduced | History |
| IMCRImmunocore Holdings plc | ADS | 2,441,830 | $76.6M | 1.7% | +1,220,036+99.9% | Added | History |
| MDTMedtronic plc | Stock | 921,043 | $80.3M | 1.8% | −17,312−1.8% | Reduced | History |
| SRRKScholar Rock Holding Corp | COM | 2,947,295 | $104.4M | 2.3% | +440,405+17.6% | Added | History |
| AKROAkero Therapeutics, Inc. | COM | 1,985,272 | $105.9M | 2.3% | +734,606+58.7% | Added | History |
| INCYIncyte Corp | COM | 1,570,333 | $106.9M | 2.4% | −521,447−24.9% | Reduced | History |
| AGIOAgios Pharmaceuticals, Inc. | COM | 3,590,150 | $119.4M | 2.6% | +75,000+2.1% | Added | History |
| RVMDRevolution Medicines, Inc. | COM | 4,579,300 | $168.5M | 3.7% | +205,000+4.7% | Added | History |
| BSXBoston Scientific Corp | Stock | 1,765,194 | $189.6M | 4.2% | −185,826−9.5% | Reduced | History |
| VRTXVertex Pharmaceuticals Inc | Stock | 441,610 | $196.6M | 4.3% | +28,539+6.9% | Added | History |
| ISRGIntuitive Surgical Inc | COM NEW | 378,728 | $205.8M | 4.5% | −47,018−11.0% | Reduced | History |
| SYKStryker Corp | Stock | 535,089 | $211.7M | 4.7% | −31,508−5.6% | Reduced | History |
| ABTAbbott Laboratories | Stock | 1,564,022 | $212.7M | 4.7% | +7,893+0.5% | Added | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 676,367 | $220.6M | 4.9% | −91,780−11.9% | Reduced | History |
| NBIXNeurocrine Biosciences Inc | Stock | 1,820,000 | $228.8M | 5.0% | 00.0% | Unchanged | History |
| IONSIonis Pharmaceuticals Inc | COM | 7,853,198 | $310.3M | 6.8% | 00.0% | Unchanged | History |
| ARGXArgenx SE | SPONSORED ADR | 571,039 | $314.8M | 6.9% | −7,835−1.4% | Reduced | History |
Sold out since Q1 2025 (13)
Positions held at the end of Q1 2025 that are gone from this filing.
| Security | Class | Shares in Q1 2025 | Value in Q1 2025 | % of portfolio in Q1 2025 | History |
|---|---|---|---|---|---|
| BRKRBruker Corp | COM | 335,288 | $14.0M | 0.3% | History |
| ESPREsperion Therapeutics, Inc. | COM | 9,694,064 | $14.0M | 0.3% | History |
| THCTenet Healthcare Corp | COM NEW | 94,722 | $12.7M | 0.3% | History |
| SRPTSarepta Therapeutics, Inc. | COM | 149,113 | $9.52M | 0.2% | History |
| CSTLCastle Biosciences Inc | COM | 301,103 | $6.03M | 0.1% | History |
| EVHEvolent Health, Inc. | CL A | 614,337 | $5.82M | 0.1% | History |
| ALTAltimmune, Inc. | COM NEW | 1,056,793 | $5.28M | 0.1% | History |
| BIOBio-Rad Laboratories, Inc. | CL A | 21,476 | $5.23M | 0.1% | History |
| ASTHAstrana Health, Inc. | COM NEW | 163,155 | $5.06M | 0.1% | History |
| RDYDr Reddys Laboratories Ltd | ADR | 91,916 | $1.21M | <0.1% | History |
| SNYSanofi | SPONSORED ADR | 16,000 | $887.4K | <0.1% | History |
| ZLABZai Lab Ltd | ADR | 20,000 | $722.8K | <0.1% | History |
| PCVXVaxcyte, Inc. | COM | 11,290 | $426.3K | <0.1% | History |